Drug class
Central Muscle Relaxants
Central muscle relaxants are a heterogeneous therapeutic class of medications that reduce skeletal muscle tone and involuntary muscle activity through actions within the brainstem or spinal cord rather than directly at the neuromuscular junction. Read more about Central Muscle Relaxants
325 drugs in this class 145 manufacturers
Drugs in Central Muscle Relaxants
BACLOFEN
FEXMID (cyclobenzaprine HCl)
CYCLOBENZAPRINE HCL
CYCLOBENZAPRINE HCL
CYCLOBENZAPRINE HCL ER (cyclobenzaprine HCl)
METAXALONE
METHOCARBAMOL
TIZANIDINE HCL
Central muscle relaxants are a heterogeneous therapeutic class of medications that reduce skeletal muscle tone and involuntary muscle activity through actions within the brainstem or spinal cord rather than directly at the neuromuscular junction.
Their principal mechanism involves modulating polysynaptic spinal reflex pathways, enhancing inhibitory neurotransmission such as GABAergic activity, or producing broader central nervous system depression.
Clinically, these agents are primarily indicated for the symptomatic relief of acute, painful musculoskeletal conditions involving localized muscle spasms, as well as chronic spasticity associated with upper motor neuron disorders like multiple sclerosis, cerebral palsy, and spinal cord injuries.
-
fda.gov
Central muscle relaxants are a heterogeneous therapeutic class of medications that reduce skeletal muscle tone and involuntary muscle activity through actions within the brainstem or spinal cord rather than directly at the neuromuscular junction
-
drugbank.com
Central muscle relaxants are a heterogeneous therapeutic class of medications that reduce skeletal muscle tone and involuntary muscle activity through actions within the brainstem or spinal cord rather than directly at the neuromuscular junction
-
nih.gov
Their principal mechanism involves modulating polysynaptic spinal reflex pathways, enhancing inhibitory neurotransmission such as GABAergic activity, or producing broader central nervous system depression Clinically, these agents are primarily indicated for the symptomatic relief of acute, painful musculoskeletal conditions involving localized muscle spasms, as well as chronic spasticity associated with upper motor neuron disorders like multiple sclerosis, cerebral palsy, and spinal cord injurie...
-
nih.gov
Their principal mechanism involves modulating polysynaptic spinal reflex pathways, enhancing inhibitory neurotransmission such as GABAergic activity, or producing broader central nervous system depression Clinically, these agents are primarily indicated for the symptomatic relief of acute, painful musculoskeletal conditions involving localized muscle spasms, as well as chronic spasticity associated with upper motor neuron disorders like multiple sclerosis, cerebral palsy, and spinal cord injurie...
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.